tiprankstipranks
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
US Market
ENDV
Endonovo Therapeutics
RESEARCH TOOLSreports
Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Revenue

24 Followers
StatisticsMarket CapRevenue

Endonovo Therapeutics Revenue

Endonovo Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 10.04K, Increased -37.33%. In the fiscal year ending Dec 31, 2025, Endonovo Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
10.04K
Revenue Growth
―
P/S Ratio
―
Revenue/Employee
$0
Employees
1
Market Cap
$180.76K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
―-10.04K-100.00%
Dec 31, 2024
10.04K-130.20K-92.84%
Dec 31, 2023
140.24K4.89K+3.61%
Dec 31, 2022
135.35K62.25K+85.15%
Mar 31, 2022
73.11K-92.69K-55.91%
Mar 31, 2021
165.80K-144.37K-46.55%
Mar 31, 2020
310.16K226.90K+272.51%
Dec 31, 2018
83.26K―+∞%
Dec 31, 2017
―――